Hannah Knowles MPS with David Batt MP, Member for Hinkler (Qld)[/caption]
Anna Theophilos MPS with David Batt MP, Member for Hinkler (Qld)[/caption]
Drawing on 17 years’ experience, Theophilos highlighted the breadth of community pharmacy services she provides, anchored by immunisation.
Using her ‘spin-to-win’ wheel, Anna highlighted the inequity experienced by patients across Australia, with regulations preventing pharmacist immunisers being able to fully support the immunisation needs of the communities they serve.
“I hope they can see it’s common sense that all pharmacists, regardless of where you practice, can vaccinate according to the Australian Immunisation Handbook. All Australians deserve the same access to vaccinations regardless of where they live.
David Peachey MPS
Professor Sarah Blunden[/caption]
Hiprex becomes a Pharmacist Only medicine
On 1 October 2025, the TGA scheduled methenamine hippurate as a Pharmacist Only medicine to ensure pharmacist oversight of its use.
Pharmacists’ skills showcased at Parliament House
Yesterday (Tuesday 7 October), PSA, in a joint event with Consumer Healthcare Products Australia (CHP Australia), showcased the breadth of pharmacists’ skills and roles...
Is Rikodeine still being rescheduled?
Last year, the TGA made an interim decision to reschedule Rikodeine to a prescription medicine. Why hasn’t it happened yet?
How pharmacists can combat poor asthma control
How pharmacists can flag SABA-only asthma patients, guide them to new therapies for optimal management, and correct inhaler technique.
Dosing off: melatonin risk for kids
Last year, it was reported that Australian poisons hotlines received almost 1,500 calls about child ingestion of melatonin.
Hiprex becomes a Pharmacist Only medicine
On 1 October 2025, the TGA scheduled methenamine hippurate as a Pharmacist Only medicine to ensure pharmacist oversight of its use.
Pharmacists’ skills showcased at Parliament House
Yesterday (Tuesday 7 October), PSA, in a joint event with Consumer Healthcare Products Australia (CHP Australia), showcased the breadth of pharmacists’ skills and roles...
Is Rikodeine still being rescheduled?
Last year, the TGA made an interim decision to reschedule Rikodeine to a prescription medicine. Why hasn’t it happened yet?
How pharmacists can combat poor asthma control
How pharmacists can flag SABA-only asthma patients, guide them to new therapies for optimal management, and correct inhaler technique.
Dosing off: melatonin risk for kids
Last year, it was reported that Australian poisons hotlines received almost 1,500 calls about child ingestion of melatonin.
POPULAR
A cup of tea, a Bex and a good lie down
Immortalised in Australian slang, the analgesic phenacetin (used in Bex powder) is wrapped up in the development of the modern pharmaceutical industry and has...
Pfizer COVID-19 vaccine health hubs announced
The Federal Government is calling on community pharmacists to help vaccinate millions of Australians against COVID-19.
Landmark Australian study on oxycodone prescribing
Oxycodone is the most prescribed strong opioid in Australia. Yet little was known about its use and prescribing patterns – until now.
Triptans downscheduled to S3 medicines
Last year, the Therapeutic Goods Administration announced that certain triptans will be available over the counter in 2021.
New CAL D instruction for antibiotics
A new cautionary advisory label for antibiotics that will replace decades of advice to take the medicines ‘until all used’ or ‘until all taken’ will be released next year.
Pharmacists help patients as Ozempic shortage gets even worse
Late last week, the TGA announced there would be no semaglutide stock from mid-November 2022 until the end of March next year.
